You are here

Prices & Quotes - UK Markets - Dechra Pharmaceuticals (DPH)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 3,198.00p
Change Today:
-16.00p
Market Cap:
3,456.84m
Sector:
Pharmaceuticals & Biotechnology
Select: Overview | Profit And Loss | Balance Sheet | Cash Flow | Key Financials

Geographical - by origin

  30-Jun-1930-Jun-1830-Jun-1730-Jun-1630-Jun-15
Revenue
Germany48.2010%40.4010%37.4110%34.1014%n/an/a
Rest of Europe163.5034%138.3034%113.1231%91.7937%99.8549%
Rest of World44.609%32.508%n/an/an/an/a11.115%
UK56.4012%56.1014%56.3216%54.4222%59.6729%
USn/an/an/an/an/an/an/an/a32.8516%
USA169.1035%139.8034%n/an/a53.9122%n/an/a
Unanalysedn/an/an/an/a152.4542%13.335%n/an/a
Total 481.80100% 407.10100% 359.30100% 247.56100% 203.48100% 
 
Profit Before Tax
Unanalysed27.80100%28.90100%28.60100%14.55100%25.81100%
Total 27.80100% 28.90100% 28.60100% 14.55100% 25.81100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  30-Jun-1930-Jun-1830-Jun-1730-Jun-1630-Jun-15
Revenue
CAPn/an/an/an/a223.8362%137.6956%n/an/a
Dietsn/an/an/an/a27.468%24.3811%n/an/a
Equinen/an/an/an/a27.258%20.529%n/an/a
European Pharmaceuticals304.0063%258.7064%n/an/an/an/an/an/a
FAPn/an/an/an/a47.3115%38.1017%n/an/a
North American Pharmaceuticals177.8037%148.4036%n/an/an/an/an/an/a
Pharmaceuticalsn/an/an/an/an/an/an/an/a203.48100%
Unanalysedn/an/an/an/a33.46n/a26.87n/an/an/a
Total 481.80100% 407.10100% 359.30100% 247.56100% 203.48100% 
 
Profit Before Tax
Pharmaceuticalsn/an/an/an/an/an/an/an/a25.81100%
Unanalysed27.80n/a28.90n/a28.60n/a14.55n/an/an/a
Total 27.80n/a 28.90n/a 28.60n/a 14.55n/a 25.81100% 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.